Welcome
-
Home
-
Register
-
Login
-
Help/FAQ
-
0 items
Search
Enter keywords, a title or
a report id number below.
In All Categories
---------------------
Telecom & Computing
Business & Finance
Mfg & Construction
Pharma & Healthcare
Consumer & Retail
Gov & Public Sector
Energy & Transport
Country Reports
Company Reports
---------------------
Transcripts
Advanced
Select a currency for use throughout the site
Australia Dollars
Canada Dollars
Euro
Japan Yen
Sweden Kroner
Switzerland Francs
UK Pounds
US Dollars
Viewing report
Order by Fax
Printer Friendly
PDF Brochure
Send to Friend
Enquire before Buying
|
More
Electronic
Stakeholder Insight: Rheumatoid Arthritis - DMARDs Gain Ground as Biologics Competition Intensifies
Datamonitor, July 2004, Pages: 192
Description
Table of Contents
Enquire before Buying
Send to a Friend
Send to a Friend
To email a friend details of
Stakeholder Insight: Rheumatoid Arthritis - DMARDs Gain Ground as Biologics Competition Intensifies
complete the form below and click on "Send".
*
Required Information
Your Friend's Details
Friend's Full Name
*
Friend's Email Address
*
A message for your Friend
Your Contact Details
Your Name
*
Email Address
*
Customers who bought this item also bought
Treatment Algorithms: Rheumatoid Arthritis 2nd Edition - Dmards Move to Front of Pack
Stakeholder Insight: Rheumatoid Arthritis - Biologics Battle Up the Treatment Algorithm
Stakeholder Insight: Inflammatory Bowel Disease - Debate over early aggressive treatment continues
Commercial and Pipeline Perspectives: Rheumatoid Arthritis - Novel Biologics Drive Innovation in the Global RA Market
Stakeholder Opinions: Systemic Lupus Erythematosus - Market Set to Enter Era of Biologic Therapies
Autoimmune Treatment (2009 - 2014)
Osteoarthritis and Rheumatoid Arthritis: Opinion Leader Forum - Expert's Views and Perspectives on Diagnosis, Treatment, Product Performance and Closing the Need Gap
Stakeholder Insight: Parkinsons Disease - Evidence of neuroprotection essential to progress treatment dynamics
Disease Modification in Rheumatoid Arthritis - The Biologics Boom
Stakeholder Opinions: Esophageal Cancer Treatment Paradigms Need Revolution Not Evolution
Stakeholder Insight: Prostate Cancer - Hormone-Refractory Patients Still Waiting For Treatment Breakthroughs
Physician Perception of Biologics in Autoimmune Disease - Targeted Detailing is the Key to Success
Top of page
All rights reserved. © Copyright 2009 Research and Markets
0
Terms and conditions
Privacy Policy
Publishers
Employment Opportunities
Site Map
Link to us
Webmaster